Skip to main content

Genasys Inc.

For the period ended Jun 30, 2025. Filed Aug 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 14, 2025

GNSS$1.41+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months EndedJune 30,
20252024
Operating Activities:
Net loss$(16,704)$(20,344)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization2,1142,193
Warranty provision(12)(56)
Inventory obsolescence254139
Loss on disposition of fixed assets16
Stock-based compensation1,2641,269
Partial release of valuation allowance—(525)
Gain on change in fair value of warrants(4,560)(21)
Loss on change in fair value of Term Loans1,380124
Loss on issuance of First Amendment Term Loan480—
Amortization of operating lease right of use asset570584
Accretion of acquisition holdback liability—15
Remeasurement of acquisition contingent consideration—(16)
Accretion of investment of marketable securities(40)—
Changes in operating assets and liabilities:
Accounts receivable, net(1,353)434
Contract assets(2,846)—
Inventories, net(4,367)(952)
Prepaid expenses and other(4,793)(3,995)
Accounts payable3,7371,776
Accrued and other liabilities13,604(641)
Net cash used in operating activities(11,271)(20,010)
Investing Activities:
Purchases of marketable securities(1,401)(11,796)
Proceeds from maturities of marketable securities9,5079,240
Cash paid for acquisitions net of cash acquired—(908)
Cash paid for asset purchase holdback liability—(764)
Capital expenditures(213)(161)
Net cash provided by (used in) investing activities7,893(4,389)
Financing Activities:
Proceeds from issuance of Close Date Term Loan and warrants, net of issuance cost—13,698
Proceeds from issuance of First Amendment Term Loan4,000—
Proceeds from exercise of stock options43—
Proceeds from offering of common stock, net of issuance costs—10,449
Payment of contingent consideration—(219)
Shares retained for payment of taxes in connection with settlement of restricted stock units(18)(12)
Net cash provided by financing activities4,02523,916
Effect of foreign exchange rate on cash82(18)
Net increase (decrease) in cash, cash equivalents, and restricted cash729(501)
Cash, cash equivalents and restricted cash, beginning of period5,2909,519
Cash, cash equivalents and restricted cash, end of period$6,019$9,018
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents$5,339$8,672
Restricted cash, current portion95—
Long-term restricted cash585346
Total cash, cash equivalents and restricted cash shown in the consolidated balance sheets$6,019$9,018

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

Nine Months EndedJune 30,
20252024
Noncash investing and financing activities:
Change in unrealized (loss) gain on marketable securities$(8)$8
Purchases of property and equipment included in accounts payable and accrued liabilities$2$—
Obligation to issue common stock in connection with the Evertel acquisition$—$(685)
Shares issued in connection with the Evertel acquisition$—$(1,924)
Settlement of Contingent consideration in shares of common stock$—$(656)
Holdback liability payable in connection with the Evertel acquisition$—$(245)
Accrued term loan and warrant issuance cost not paid$—$(119)
Supplemental disclosure of cash flow information
Cash paid for interest$1,124$—
Cash paid for taxes$39$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.